Published Date: May 31, 2023

Full Text Article

Combined liver-kidney transplant in polycystic diseases: a case report

Authors: Olival Cirilo Lucena da Fonseca Neto, Beatriz Costa Nava Martins, Norma Thomé Jucá, Victor Cruz Rosa Alencar de Sá, Priscylla Jennie Monteiro Rabêlo, Paulo Sérgio Vieira de Melo, Américo Gusmão Amorim, Cláudio Moura Lacerda

Einstein (Sao Paulo). 2023 May 29;21:eRC0282. doi: 10.31744/einstein_journal/2023RC0282. eCollection 2023.


Polycystic liver disease, a hereditary pathology, usually manifests as autosomal dominant polycystic kidney disease. The many cysts in the liver cause massive hepatomegaly, majorly affecting the patient's quality of life. In cases of refractory symptoms, liver transplantation is the only treatment choice. A 43-year-old woman was followed up as a hepatology outpatient in August 2020, with a progressive increase in abdominal volume, lower limb edema, and cachexia. The patient was diagnosed with polycystic renal and liver disease with massive hepatomegaly in March 2021, a combined kidney-liver transplant. Liver size represented 13% of the patient's corporal composition, weighing 8.6kg. The patient was discharged on the 7th postoperative day with no complications. Only 10-20% of patients with polycystic liver disease have clinical manifestations, most of which result from hepatomegaly. An increase in liver volume deteriorates liver function until the condition becomes end-stage liver disease, as kidney function is already compromised; liver-kidney transplantation remains the only treatment choice. The case described drew significant attention to the massive hepatomegaly presented in the patient, with the liver representing over 10% of the patient's body weight, approximately five to six times larger than a normal-sized liver.

PMID: 37255062DOI: 10.31744/einstein_journal/2023RC0282PMC: PMC10219621